CAPECITABINE vs INLEXZO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. CAPECITABINE and INLEXZO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CAPECITABINE	INLEXZO
Rating	New	New
Pharmacy pays	~$14.21 /30	~$599.88 /30
Type	RX	RX
Active ingredient	CAPECITABINE	GEMCITABINE HYDROCHLORIDE
Manufacturer	Msn	Janssen Biotech
Dosage forms	Tablet	System
Drug class	Nucleoside Metabolic Inhibitor	Nucleoside Metabolic Inhibitor
Boxed warning	Boxed warning	None
Treats	Breast Neoplasms, Colorectal Neoplasms	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Ovarian Neoplasms

capecitabine inlexzo

Rating

New

Pharmacy pays

~$14.21 /30

~$599.88 /30

Type

Active ingredient

CAPECITABINE

GEMCITABINE HYDROCHLORIDE

Manufacturer

Msn

Janssen Biotech

Dosage forms

Tablet

System

Drug class

Nucleoside Metabolic Inhibitor

Boxed warning

None

Treats

Breast Neoplasms, Colorectal Neoplasms

Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Ovarian Neoplasms

Frequently asked questions

Which is cheaper, Capecitabine or Inlexzo?

Capecitabine costs pharmacies less to acquire — about $14.21 vs $599.88 for a 30-count supply, per the CMS NADAC survey. That gap is in the pharmacy's cost of goods, not necessarily in what you pay: your price is set afterwards by your insurer and the pharmacy.

What is the difference between Capecitabine and Inlexzo?

Capecitabine contains Capecitabine, while Inlexzo contains Gemcitabine Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.